Globeways Holdings Ltd
CIK 0001600769 Name as filed on the most recent filing
Filed as Globeways Holdings Ltd (7)
39 transaction lines · from 7 filings · filed 2014-06-13 to 2021-01-14 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Cullinan Management, Inc. 1 filings
- ISSUER Tcr2 Therapeutics Inc. 5 filings
- ISSUER Radius Health, Inc. 1 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2021-01-12 |
Cullinan Management, Inc. CGEM |
P, Open-market purchase | 104,762 acquired | 21.00 | 2,200,002.00 | Form 4, filing 0000899243-21-002048 | |
| 2021-01-12 |
Cullinan Management, Inc. CGEM |
P, Open-market purchase | 95,238 acquired | 21.00 | 1,999,998.00 | Form 4, filing 0000899243-21-002048 | |
| 2019-12-19 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 35,323 disposed | 16.47 | 581,819.26 | Form 4, filing 0000899243-19-029791 | |
| 2019-12-19 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 6,642 disposed | 16.47 | 109,403.04 | Form 4, filing 0000899243-19-029791 | |
| 2019-12-18 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 2,433 disposed | 17.01 | 41,375.60 | Form 4, filing 0000899243-19-029791 | |
| 2019-12-18 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 458 disposed | 17.01 | 7,788.75 | Form 4, filing 0000899243-19-029791 | |
| 2019-12-11 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 4,153 disposed | 17.65 | 73,310.83 | Form 4, filing 0000899243-19-028968 | |
| 2019-12-11 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 1,381 disposed | 17.65 | 24,378.10 | Form 4, filing 0000899243-19-028968 | |
| 2019-12-11 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 1,155 disposed | 17.65 | 20,388.64 | Form 4, filing 0000899243-19-028968 | |
| 2019-12-11 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 1,054 disposed | 17.65 | 18,605.74 | Form 4, filing 0000899243-19-028968 | |
| 2019-12-10 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 30,475 disposed | 17.62 | 537,067.02 | Form 4, filing 0000899243-19-028968 | |
| 2019-12-10 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 10,135 disposed | 17.62 | 178,611.13 | Form 4, filing 0000899243-19-028968 | |
| 2019-12-10 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 8,479 disposed | 17.62 | 149,427.11 | Form 4, filing 0000899243-19-028968 | |
| 2019-12-10 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 7,741 disposed | 17.62 | 136,421.19 | Form 4, filing 0000899243-19-028968 | |
| 2019-12-09 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 75,067 disposed | 17.65 | 1,325,015.12 | Form 4, filing 0000899243-19-028968 | |
| 2019-12-09 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 24,966 disposed | 17.65 | 440,677.36 | Form 4, filing 0000899243-19-028968 | |
| 2019-12-09 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 20,886 disposed | 17.65 | 368,660.87 | Form 4, filing 0000899243-19-028968 | |
| 2019-12-09 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 19,070 disposed | 17.65 | 336,606.48 | Form 4, filing 0000899243-19-028968 | |
| 2019-10-22 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 2,085 disposed | 15.16 | 31,602.55 | Form 4, filing 0000899243-19-025909 | |
| 2019-10-22 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 693 disposed | 15.16 | 10,503.87 | Form 4, filing 0000899243-19-025909 | |
| 2019-10-22 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 580 disposed | 15.16 | 8,791.12 | Form 4, filing 0000899243-19-025909 | |
| 2019-10-22 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 530 disposed | 15.16 | 8,033.26 | Form 4, filing 0000899243-19-025909 | |
| 2019-09-23 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 5,516 disposed | 17.31 | 95,489.68 | Form 4, filing 0000899243-19-024208 | |
| 2019-09-23 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 1,835 disposed | 17.31 | 31,766.42 | Form 4, filing 0000899243-19-024208 | |
| 2019-09-23 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 1,535 disposed | 17.31 | 26,573.00 | Form 4, filing 0000899243-19-024208 | |
| 2019-09-23 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 1,401 disposed | 17.31 | 24,253.27 | Form 4, filing 0000899243-19-024208 | |
| 2019-09-23 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 683 disposed | 17.31 | 11,823.69 | Form 4, filing 0000899243-19-024208 | |
| 2019-09-23 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 351 disposed | 17.31 | 6,076.30 | Form 4, filing 0000899243-19-024208 | |
| 2019-09-20 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 197,343 disposed | 17.94 | 3,539,425.64 | Form 4, filing 0000899243-19-024208 | |
| 2019-09-20 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 65,633 disposed | 17.94 | 1,177,154.11 | Form 4, filing 0000899243-19-024208 | |
| 2019-09-20 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 54,907 disposed | 17.94 | 984,779.01 | Form 4, filing 0000899243-19-024208 | |
| 2019-09-20 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 50,134 disposed | 17.94 | 899,173.34 | Form 4, filing 0000899243-19-024208 | |
| 2019-09-20 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 24,446 disposed | 17.94 | 438,448.79 | Form 4, filing 0000899243-19-024208 | |
| 2019-09-20 |
Tcr2 Therapeutics Inc. TCRR |
S, Open-market sale | 12,537 disposed | 17.94 | 224,856.11 | Form 4, filing 0000899243-19-024208 | |
| 2019-02-19 |
Tcr2 Therapeutics Inc. TCRR |
P, Open-market purchase | 200,000 acquired | 15.00 | 3,000,000.00 | Form 4, filing 0000899243-19-004404 | |
| 2019-02-19 |
Tcr2 Therapeutics Inc. TCRR |
P, Open-market purchase | 166,667 acquired | 15.00 | 2,500,005.00 | Form 4, filing 0000899243-19-004404 | |
| 2019-02-19 |
Tcr2 Therapeutics Inc. TCRR |
P, Open-market purchase | 166,667 acquired | 15.00 | 2,500,005.00 | Form 4, filing 0000899243-19-004404 | |
| 2019-02-19 |
Tcr2 Therapeutics Inc. TCRR |
P, Open-market purchase | 133,333 acquired | 15.00 | 1,999,995.00 | Form 4, filing 0000899243-19-004404 | |
| 2014-06-11 |
Radius Health, Inc. RDUS |
P, Open-market purchase | 587,500 acquired | 8.00 | 4,700,000.00 | Form 4, filing 0001140361-14-025611 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Globeways Holdings Ltd, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001600769
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6